Gonal-F® pen

Indicated for:

Women:

·         Anovulation including polycystic ovarian syndrome in women who have been unresponsive to treatment with clomiphene citrate (helping release an egg from the ovary in women that cannot ovulate).

·         Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and zygote intra-fallopian transfer (helping develop several follicles in women undergoing procedures that may help to become pregnant).

·         GONAL-f in association with a luteinising hormone (LH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency (helping release egg from the ovary in women that are not ovulating because their body is producing very little gonadotropins). In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/l.

Men:

-          Stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human Chorionic Gonadotropin (hCG) therapy (helping produce sperm in men that are infertile due to a low level of certain hormones).